Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Quanterix Corp (QTRX)

Healthcare Medical Devices
3.50 $
-1.1% vs. previous close
Closing price · As of: 31. Jul 2026
🔔 Watch stock

Stock Watch

Stock Watch will tell you what changes at Quanterix Corp.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Appears in These Scanners

This stock currently matches 6 of our scanner strategies — each hit links to the scanner.

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners

Basics

Market Cap
0.2$B
Shares Outstanding
47Mio.
Float
81.7%
Beta
1.0

Performance

Perf. 1M
48.90%
Perf. 3M
26.80%
Perf. 6M
-31.40%
YTD Performance (%)
-49.40%
52-Week-High Distance
-57.1%
Perf. 1Y
-40.00%
Perf. 3Y
-85.60%
Perf. 5Y
-94.00%

Valuation

P/E
Forward P/E
0.0
PEG
P/B
P/S
1.1
EV/EBITDA
-1.5
Price/FCF

Profitability

Gross Margin
45.3%
EBIT Margin
Net Margin
-71.9%
Return on Equity
-34.8%
Return on Assets
-13.4%

Balance Sheet & Safety

Equity Ratio
Debt/Equity
Altman Z″
1.96
Piotroski
3 out of 9

Growth

Sales Growth Last Quarter
20.10%
EPS Growth Last Quarter
0.00%
Sales Growth (Year)
2.38%
Forward Sales Growth
10.97%
Forward EPS Growth
-10.60%

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage
4
RS Rating
7
EPS Rating
42
Piotroski
3 out of 9
Fundamental Rating
D (44 out of 100)
Altman Z″
1.96

AI Rating

Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built

Analysts & Price Target

Current Price 3.50 $
Price Target (average) 4.33 $

The price target sits 23.7% above the current price.

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Next Reporting Date

6. Aug 2026 · after the close · Q2 2026
Expected Earnings per Share
-0.56 $

Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 34.1 $M Q4 2025: Q1 · 30.3 $M Q1 2025: Q2 · 24.5 $M Q2 2025: Q3 · 40.1 $M Q3 2025: Q4 · 43.9 $M Q4 2026: Q1 · 36.4 $M Q1

Source: fundamental data

Compare with other stocks →

Quarterly Figures

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 -0.30 34 9.30 -34.10 -4 -5
2025: Q1 -0.53 30 -4.80 -67.70 -14 -15
2025: Q2 -0.77 25 -28.30 -122.70 -6 -6
2025: Q3 -0.73 40 13.40 -83.50 -41 -42
2025: Q4 -0.49 44 28.60 -52.70 -16 -16
2026: Q1 -0.37 36 20.30 -48.20 -18 -18
What Do These Terms Mean?
EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

About the Company

Quanterix Corporation, ein Life-Sciences-Unternehmen in Nordamerika, Europa, dem Nahen Osten, Afrika und dem asiatisch-pazifischen Raum. Das Unternehmen bietet das HD-X-Instrument, eine Plattform zur Proteindetektion, sowie das SR-X-Instrument an, das Forschern die Simoa-Detektion in einem erweiterten Anwendungsbereich ermöglicht…

Employees450
HeadquartersBillerica, MA
Websitequanterix.com
IPO Date7. Dec 2017

Management

Management
Name Title Birth Year
William P. Donnelly Executive Chair 1962
David R. Walt Ph.D. Co-Founder & Chairman of Scientific Advisory Board 1953
Everett V. Cunningham President, CEO & Director 1966
Jason Faessler CFO & Treasurer
Anthony Catalano Chief Operating Officer
Jerzy Olejnik Chief Technology Officer
Joshua Young Head of Investor Relations
Daniel S. Char J.D. Chief Legal Officer & Corporate Secretary 1961
Naren Bhat Senior Vice President of Corporate Development & Strategy
Erica Bell Chief People Officer 1973

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
15. Jul 2026 Miller Michael Francis Chief Technology Officer Other 249 4.24 1,056
15. Jul 2026 Miller Michael Francis Chief Technology Officer Other 834
15. Jul 2026 Miller Michael Francis Chief Technology Officer Other 111 4.24 471
15. Jul 2026 Miller Michael Francis Chief Technology Officer Other 372
15. Jul 2026 Miller Michael Francis Chief Technology Officer Other 135
15. Jul 2026 Miller Michael Francis Chief Technology Officer Other 41 4.24 174
15. Jul 2026 Miller Michael Francis Chief Technology Officer Other 136
15. Jul 2026 Miller Michael Francis Chief Technology Officer Other 25 4.24 106
15. Jul 2026 Miller Michael Francis Chief Technology Officer Other 81
8. Jul 2026 Mendel Scott Director Other 8,073

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Chart

Interactive price chart (TradingView).

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?